Skip to main content
OpenTrials

Clinical trial condition

Neuroinflammatory Diseases

Explore clinical trials studying Neuroinflammatory Diseases. Study availability and eligibility vary by location and protocol.

1,039 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Neuroinflammatory Diseases trial results

Completed

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

NCT03282370

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Hoa Binh Provincial Preventive Medicine Center Hòa Bình, Hoa Binh, Vietnam
  • Hoa Binh City Health Center Hòa Bình, Hoa Binh, Vietnam
  • District Health Center Thanh Sơn, Phu Tho, Vietnam
  • Phu Tho Preventive Medicine Center Viet Tri, Phu Tho, Vietnam
View Trial Details
Completed

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

NCT03204227

Conditions
Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations
  • Hoa Binh Provincial Preventive Medicine Center Hòa Bình, Hoa Binh, Vietnam
  • Hoa Binh City Health Center Hòa Bình, Hoa Binh, Vietnam
  • District Health Center Thanh Sơn, Phu Tho, Vietnam
  • Phu Tho Preventive Medicine Center Viet Tri, Phu Tho, Vietnam
View Trial Details
Completed

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

NCT03226119

Conditions
Central Nervous System Diseases, Central Nervous System Infections, Deltaretrovirus Infections, +28 more
Locations
  • LABS, Inc. Philadelphia, Pennsylvania, United States
  • Qualtex Laboratories San Antonio, Texas, United States
  • Eastern Virginia Medical School (EVMS) Norfolk, Virginia, United States
View Trial Details
Completed

Safety and Immunogenicity of GlaxoSmithKline Biologicals Meningococcal Group B Vaccine When Administered Concomitantly With GlaxoSmithKline Biologicals MenACWY Conjugate Vaccine to Healthy Infants

NCT02106390

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Diseases, +8 more
Locations
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Buenos Aires, Argentina
  • GSK Investigational Site Córdoba, Argentina
  • GSK Investigational Site Mexico City, Mexico
View Trial Details
Completed

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

NCT01248884

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +32 more
Locations
  • GSK Investigational Site Santo Domingo, Dominican Republic
  • GSK Investigational Site Santo Domingo, Distrito Nacional, Dominican Republic
  • GSK Investigational Site Espoo, Finland
  • GSK Investigational Site Helsinki, Finland
View all 16 locations
View Trial Details
Completed

Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants

NCT01090453

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +33 more
Locations
  • GSK Investigational Site Vancouver, British Columbia, Canada
  • GSK Investigational Site Winnipeg, Manitoba, Canada
  • GSK Investigational Site Hamilton, Ontario, Canada
  • GSK Investigational Site Aix-en-Provence, France
View all 34 locations
View Trial Details
Completed

Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children

NCT01245049

Conditions
Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
Locations
  • GSK Investigational Site St Austell, Cornwall, United Kingdom
  • GSK Investigational Site Southampton, Hampshire, United Kingdom
  • GSK Investigational Site Axbridge, Somerset, United Kingdom
  • GSK Investigational Site Taunton, Somerset, United Kingdom
View all 13 locations
View Trial Details

Related conditions